id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-331541-u0xm9a89	Lankes, Heather A	Biospecimen Collection During the COVID-19 Pandemic: Considerations for Biobanking	2020-09-25		.txt	text/plain	3580	250	40	METHODS: Centers for Disease Control and Prevention and World Health Organization severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) interim biosafety guidelines continue to be updated. Additional CDC SARS guidance recommended that laboratory personnel have a baseline serum sample collected prior to working with SARS-CoV biospecimens and stored for future reference. Testing of banked biospecimens collected in late 2019 may help define asymptomatic (or mildly symptomatic) circulation of SARS-CoV-2 prior to the presentation of severe cases in December; however, until a more accurate date is defined, use of October 1, 2019, as the start of the pandemic window is reasonable. Per CDC and WHO SARS-CoV-2 interim biosafety guidance 48, 49 and reported COVID-19 experience, 57 biobanks handling pandemic window biospecimens must: SARS-CoV-2 is the highly transmittable respiratory virus that causes COVID-19, a disease hallmarked by asymptomatic infection in some, and severe symptoms, including death, in others.	./cache/cord-331541-u0xm9a89.txt	./txt/cord-331541-u0xm9a89.txt